Covestor LTD Abbott Laboratories Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Covestor LTD holds 1,837 shares of ABT stock, worth $211,806. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,837

Previous 2,263 18.82%

Holding current value

$211,806

Previous $235,000 11.06%

% of portfolio

0.13%

Previous 0.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $42,629 - $50,323	-426 Reduced 18.82%	1,837 $209,000
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $105,061 - $117,274	1,043 Added 85.49%	2,263 $235,000
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $38,879 - $42,940	-355 Reduced 22.54%	1,220 $139,000
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $4,238 - $5,188	47 Added 3.08%	1,575 $173,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $8,406 - $10,086	88 Added 6.11%	1,528 $148,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $2,317 - $2,582	-23 Reduced 1.57%	1,440 $157,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $58,890 - $69,318	-608 Reduced 29.36%	1,463 $148,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $11,312 - $13,270	-119 Reduced 5.43%	2,071 $227,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $21,383 - $24,758	-221 Reduced 9.17%	2,190 $212,000
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $4,899 - $5,921	-48 Reduced 1.95%	2,411 $262,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $114,818 - $140,013	1,007 Added 69.35%	2,459 $291,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $167,749 - $205,399	1,452 New	1,452 $204,000

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account